As cancer continues to be a leading cause of mortality worldwide, there is a growing urgency to develop innovative oncolytic virus therapies that can effectively target and eradicate cancer cells. With its unique ability to selectively infect and replicate within tumor cells, oncolytic virus therapy has emerged as a promising avenue in cancer treatment. Key factors driving oncolytic virus treatment market growth include increasing research and development activities, growing investments from pharmaceutical companies, and expanding oncolytic virus clinical trial pipelines.
With ongoing advancements and strategic collaborations, oncolytic virus therapy is positioned ...
